Sovevax Biologics Profile
Key Indicators
- Authorised Capital ₹ 100.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 100.00 Cr
as on 16-11-2024
- Company Age 3 Year, 12 Days
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2023)
- Profit 86.32%
(FY 2023)
- Ebitda 82.07%
(FY 2023)
- Net Worth 266.25%
(FY 2023)
- Total Assets 602.54%
(FY 2023)
About Sovevax Biologics
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 100.00 Cr and a paid-up capital of Rs 100.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Sovevax Biologics Private Limited India is Sunny Shah as COMPANY SECRETARY. Kairus Dadachanji, Soumitra Bhattacharyya, Saurabh Prabhudesai, and One other member serve as directors at the Company.
- CIN/LLPIN
U24290MH2021PTC373037
- Company No.
373037
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Dec 2021
- Date of AGM
26 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Sovevax Biologics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sunny Shah | Company Secretary | 01-Oct-2022 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saurabh Prabhudesai  | Director | 06-Jun-2023 | Current |
| Rishad Dadachanji | Director | 09-Dec-2021 | Current |
| Kairus Dadachanji | Director | 09-Dec-2021 | Current |
Soumitra Bhattacharyya  | Director | 06-Jun-2023 | Current |
Financial Performance and Corporate Structure Insights of Sovevax Biologics.
Sovevax Biologics Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 86.32% increase in profit. The company's net worth Soared by an impressive increase of 266.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sovevax Biologics?
In 2023, Sovevax Biologics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sovereign Pharma Private LimitedActive 21 years 6 monthsKairus Dadachanji and Rishad Dadachanji are mutual person
Kaisha Packaging Private LimitedActive 17 years 4 monthsKairus Dadachanji and Rishad Dadachanji are mutual person
Kairish Innotech Private LimitedActive 4 years 5 monthsKairus Dadachanji and Rishad Dadachanji are mutual person
Kaisha Lifesciences Private LimitedActive 14 years 5 monthsKairus Dadachanji and Rishad Dadachanji are mutual person
Poonawalla Estates Stud And Agri Farm Privae LimitedActive 18 years 8 monthsSaurabh Prabhudesai is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sovevax Biologics?
Unlock and access historical data on people associated with Sovevax Biologics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sovevax Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sovevax Biologics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
